InfiNovo Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Investors
  • 4

InfiNovo General Information


Developer of a biosensor and application products designed to service in healthcare sector. The company focuses on chronic disease detection device and treatment standards and provides technological sensor tools for chronic disease treatment, enabling users to improve diagnostic accuracy and receive better treatment in an efficient way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Primary Office
  • B2 building
  • No.218 Xinghu Street
  • Suzhou, Jiangsu
  • China
+86 0512 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InfiNovo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 28-Jul-2020 Completed Generating Revenue
2. Early Stage VC (Series A1) 03-Feb-2019 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jul-2018 Completed Startup
To view InfiNovo’s complete valuation and funding history, request access »

InfiNovo Executive Team (1)

Name Title Board Seat Contact Info
Rongen Cheng Director & General Manager
To view InfiNovo’s complete executive team members history, request access »

InfiNovo Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vertex Ventures China Venture Capital Minority 000 0000 000000 0
Loyal Valley Capital Growth/Expansion Minority 000 0000 000000 0
Prosperico Ventures Venture Capital Minority 000 0000 000000 0
Rongan Venture Capital Venture Capital Minority 000 0000 000000 0
To view InfiNovo’s complete investors history, request access »